Tag: #Global Trends

The Prescription Medicines Code of Practice Authority (PMCPA) in the UK has sanctioned Sanofi following controversial remarks made by its... Read more

AstraZeneca’s application for a subcutaneous (SC) version of its lupus therapy, Saphnelo, has been rejected by the U.S. Food and... Read more

The push into biologics addresses rising domestic rates of diabetes and cancer while pursuing broader economic objectives: Reducing Import Dependency:... Read more

The Ontario Court of Justice has issued a 750,000 CAD fine (approximately 14 billion VND) against the Estée Lauder group... Read more

Pharmaceutical giant Eli Lilly has unveiled plans to construct a major production facility for injectable medicines and delivery devices in... Read more

Amidst a surge in domestic production investments, the FDA has officially launched the PreCheck pilot program. This initiative is designed... Read more

The global pharmaceutical landscape is witnessing significant shifts driven by health regulators in the U.S. (FDA), Europe (EMA), and China... Read more

Ardena has successfully finalized the divestment of its active pharmaceutical ingredient (API) facility in Södertälje, Sweden, to Nanologica AB. Following... Read more

Veeva Systems has unveiled Veeva eSource, a new application within its SiteVault platform designed to streamline clinical trial data flow.... Read more